News | January 25, 2013

Elekta, Philips Gain MD Anderson Cancer Center as Collaborator on MRI-Guided Radiation Therapy

The University of Texas MD Anderson Cancer Center joins group dedicated to developing the next-generation innovation for treatment of cancer patients using radiotherapy

January 25, 2013 — Elekta and Philips Healthcare announced The University of Texas MD Anderson Cancer Center (Houston, Texas) has signed an agreement to join a research group to advance the development of an innovative image-guided treatment technology for cancer care. The technology merges radiation therapy and magnetic resonance imaging (MRI) technology in a single system. MD Anderson is the second member of the research consortium, which will comprise leading radiation oncology centers and clinicians, and already includes the University Medical Center Utrecht (the Netherlands).

Uniting state-of-the-art MRI with a cutting edge radiation therapy system — thus creating an MRI-guided radiation therapy system — will provide physicians with exceptional images of a patient’s soft tissues and tumor during radiation therapy. This breakthrough innovation also aims to enable clinicians to adapt treatment delivery in real time for the most precise cancer treatments possible.

“The special capabilities of the MRI-guided radiation therapy system — MR-based soft tissue imaging performed simultaneously with treatment delivery — could revolutionize cancer care,” says Jay Hoey, executive vice president, Elekta North America. “Patients are the ultimate winners, because MR imaging will help put the therapeutic radiation right on target, with the potential to avoid exposure to normal tissues. My colleagues at Elekta, Philips and University Medical Center Utrecht are thrilled to welcome MD Anderson to the research consortium, which will profit immensely from this center’s high-caliber medical, technological and patient care expertise.”

“MRI is the gold standard modality for imaging soft tissues, and MR imaging of the cancer during radiation therapy could provide the health care team the ability to optimize treatment while reducing toxicity,” says Steven J. Frank, M.D., associate professor of Radiation Oncology and director of Advanced Technologies at MD Anderson. “Our collaborative research will focus on what this combination could mean for patients in the future.”

“The development of a meaningful, yet complex innovation like the MRI-guided radiation therapy system can only be done in partnership with leading healthcare innovators, both from an industrial, as well as a clinical perspective,” says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. “As a leading innovator in cancer care, the University of Texas MD Anderson Cancer Center will bring their unique expertise to help realize the promise of more targeted cancer treatments and transform the way healthcare is delivered today.”

Prior to the establishment of the research consortium, Elekta, Philips and the University Medical Center Utrecht have built and tested a prototype system that integrates a linear accelerator and a 1.5 Tesla MRI system. The success of these efforts has enabled the project to move to the next phase of development and testing by the select group of consortium partners.

Radiation therapy and medical imaging already play an essential role in treatment planning, delivery and after care, and are proven, cost-effective and safe methods for the treatment of individuals with cancer. Radiotherapy is a critical modality for cancer treatment, either as a frontline treatment or used with other modalities, such as chemotherapy. The procedure involves identifying cancerous tissue and irradiating it with high-energy radiation beams in a way that maximizes sparing of healthy tissues near the tumor.

The integrated MRI-guided radiation therapy system is in development and not available for sale.

For more information: www.elekta.com, www.philips.com/newscenter

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...